Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor
Objective: To assess the prevalence and risk factors of erectile dysfunction (ED) in HIV patients from the HIV clinic of a tertiary referral center in Mexico City. Design: Prevalence was obtained from cross‐sectional studies, and the International Index of Erectile Function (IIEF), a standardized me...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2014-04-01
|
| Series: | Sexual Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2050116115300258 |
| _version_ | 1797714215526465536 |
|---|---|
| author | Gustavo Romero‐Velez, MD Andrés Lisker‐Cervantes, MD Christian I. Villeda‐Sandoval, MD Mariano Sotomayor de Zavaleta, MD Daniel Olvera‐Posada, MD Juan Gerardo Sierra‐Madero, MD Lucrecia O. Arreguin‐Camacho, MD Ricardo A. Castillejos‐Molina, MD |
| author_facet | Gustavo Romero‐Velez, MD Andrés Lisker‐Cervantes, MD Christian I. Villeda‐Sandoval, MD Mariano Sotomayor de Zavaleta, MD Daniel Olvera‐Posada, MD Juan Gerardo Sierra‐Madero, MD Lucrecia O. Arreguin‐Camacho, MD Ricardo A. Castillejos‐Molina, MD |
| author_sort | Gustavo Romero‐Velez, MD |
| collection | DOAJ |
| description | Objective: To assess the prevalence and risk factors of erectile dysfunction (ED) in HIV patients from the HIV clinic of a tertiary referral center in Mexico City.
Design: Prevalence was obtained from cross‐sectional studies, and the International Index of Erectile Function (IIEF), a standardized method, was used to assess ED.
Methods: A cross‐sectional study was performed in the HIV clinic. Participants completed the IIEF to allow ED assessment. Information on demographics, clinical and HIV‐related variables was retrieved from their medical records.
Results: One hundred and nine patients were included, with a mean age of 39.9 ± 8.8 years. ED was present in 65.1% of the individuals. Patients had been diagnosed with HIV for a mean of 92.7 ± 70.3 months and had undergone a mean 56.4 ± 45.5 months of HAART. The only variable associated with ED in the univariate analysis was dyslipidemia, and this association was also found in the multivariate analysis (P = 0.01).
Conclusions: ED is highly prevalent in HIV patients. Dyslipidemia should be considered as a risk factor for ED in HIV patients. Romero‐Velez G, Lisker‐Cervantes A, Villeda‐Sandoval CI, Sotomayor de Zavaleta M, Olvera‐Posada D, Sierra‐Madero JG, Arreguin‐Camacho LO, and Castillejos‐Molina RA. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: Dyslipidemia as a main risk factor. Sex Med 2014;2:24–30. |
| first_indexed | 2024-03-12T07:48:30Z |
| format | Article |
| id | doaj.art-3649907b05fa414586f843d8e5b785d3 |
| institution | Directory Open Access Journal |
| issn | 2050-1161 |
| language | English |
| last_indexed | 2024-03-12T07:48:30Z |
| publishDate | 2014-04-01 |
| publisher | Oxford University Press |
| record_format | Article |
| series | Sexual Medicine |
| spelling | doaj.art-3649907b05fa414586f843d8e5b785d32023-09-02T20:48:44ZengOxford University PressSexual Medicine2050-11612014-04-0121243010.1002/sm2.25Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk FactorGustavo Romero‐Velez, MD0Andrés Lisker‐Cervantes, MD1Christian I. Villeda‐Sandoval, MD2Mariano Sotomayor de Zavaleta, MD3Daniel Olvera‐Posada, MD4Juan Gerardo Sierra‐Madero, MD5Lucrecia O. Arreguin‐Camacho, MD6Ricardo A. Castillejos‐Molina, MD7Urology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoUrology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoUrology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoUrology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoUrology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoInfectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoInfectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoUrology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoObjective: To assess the prevalence and risk factors of erectile dysfunction (ED) in HIV patients from the HIV clinic of a tertiary referral center in Mexico City. Design: Prevalence was obtained from cross‐sectional studies, and the International Index of Erectile Function (IIEF), a standardized method, was used to assess ED. Methods: A cross‐sectional study was performed in the HIV clinic. Participants completed the IIEF to allow ED assessment. Information on demographics, clinical and HIV‐related variables was retrieved from their medical records. Results: One hundred and nine patients were included, with a mean age of 39.9 ± 8.8 years. ED was present in 65.1% of the individuals. Patients had been diagnosed with HIV for a mean of 92.7 ± 70.3 months and had undergone a mean 56.4 ± 45.5 months of HAART. The only variable associated with ED in the univariate analysis was dyslipidemia, and this association was also found in the multivariate analysis (P = 0.01). Conclusions: ED is highly prevalent in HIV patients. Dyslipidemia should be considered as a risk factor for ED in HIV patients. Romero‐Velez G, Lisker‐Cervantes A, Villeda‐Sandoval CI, Sotomayor de Zavaleta M, Olvera‐Posada D, Sierra‐Madero JG, Arreguin‐Camacho LO, and Castillejos‐Molina RA. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: Dyslipidemia as a main risk factor. Sex Med 2014;2:24–30.http://www.sciencedirect.com/science/article/pii/S2050116115300258Erectile DysfunctionHIVHAARTDyslipidemiaIIEFAIDS |
| spellingShingle | Gustavo Romero‐Velez, MD Andrés Lisker‐Cervantes, MD Christian I. Villeda‐Sandoval, MD Mariano Sotomayor de Zavaleta, MD Daniel Olvera‐Posada, MD Juan Gerardo Sierra‐Madero, MD Lucrecia O. Arreguin‐Camacho, MD Ricardo A. Castillejos‐Molina, MD Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor Sexual Medicine Erectile Dysfunction HIV HAART Dyslipidemia IIEF AIDS |
| title | Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor |
| title_full | Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor |
| title_fullStr | Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor |
| title_full_unstemmed | Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor |
| title_short | Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor |
| title_sort | erectile dysfunction among hiv patients undergoing highly active antiretroviral therapy dyslipidemia as a main risk factor |
| topic | Erectile Dysfunction HIV HAART Dyslipidemia IIEF AIDS |
| url | http://www.sciencedirect.com/science/article/pii/S2050116115300258 |
| work_keys_str_mv | AT gustavoromerovelezmd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT andresliskercervantesmd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT christianivilledasandovalmd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT marianosotomayordezavaletamd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT danielolveraposadamd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT juangerardosierramaderomd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT lucreciaoarreguincamachomd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor AT ricardoacastillejosmolinamd erectiledysfunctionamonghivpatientsundergoinghighlyactiveantiretroviraltherapydyslipidemiaasamainriskfactor |